PharmaSi SRL
PharmaSi reported total assets of 58,595 € at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Aug 2026).
The score of PharmaSi shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -53 % Total assets -51 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
PharmaSi's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Aug 2026
- Year ended 31 Dec 2024filed on 22 Aug 2025
- Year ended 31 Dec 2023filed on 16 Jul 2024
- Year ended 31 Dec 2022filed on 27 Jul 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
PharmaSi's financial analysis
- Solvency89.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of PharmaSi
PharmaSi's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0687.947.061
- VAT number
- BE0687947061
- Peppol
- Registered · 0208:0687947061 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Jan 2018
- Registered office
- 3630 Maasmechelen
- Latest accounts
- 2025 · filed on 25 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
PharmaSi (SRL) has been based in Maasmechelen since 2018, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 23,327 € and equity of 52,289 €; its revenue is not published. Its solvency stands at 89.2%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to PharmaSi
Companies in the same business, of comparable size and area, outside its group.
- Jiwan Activities of holding companies Antwerp · balance sheet 198,041 €
- Benisa BV Retail sale of pharmaceutical products Dilsen-Stokkem · balance sheet 60,407 €
- Begis Retail sale of pharmaceutical products Oosterzele · balance sheet 43,714 €
- Pharmacie Thauvin Retail sale of pharmaceutical products Ciney · balance sheet 156,263 €
- Mancha Retail sale of pharmaceutical products Edegem · balance sheet 264,945 €
- Apotheek Schoofs Kristie Retail sale of pharmaceutical products Oudsbergen · balance sheet 412,440 €
- Talpa Farma Retail sale of pharmaceutical products Anderlecht · balance sheet 547,932 €
- Satilmis Retail sale of pharmaceutical products Saint-Gilles · balance sheet 304,962 €
Frequently asked questions about PharmaSi
What is the revenue of PharmaSi?
PharmaSi files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of PharmaSi?
In Belgium, the VAT number is the company number prefixed with BE: BE0687947061 for PharmaSi, if the company is VAT-registered. Its company number (CBE) is 0687.947.061.
Where is the registered office of PharmaSi?
According to the CBE register, the registered office of PharmaSi is in 3630 Maasmechelen.
What is the equity of PharmaSi?
At the close of the 2025 financial year, the equity of PharmaSi amounts to 52,289 €, a solvency of 89.2% of total assets.
Who manages PharmaSi?
The register lists 1 active mandates at PharmaSi. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of PharmaSi
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →